A reformulated RLS-2201 is being produced at BioCina’s sterile manufacturing facility in Perth, under conditions designed to confirm the reproducibility and robustness of the manufacturing process.
Apiject Holdings, Inc. has announced the signing of a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina. The facility will house two advanced Blow-Fill-Seal ...
ROIS adds a US sterile fill-finish hub, enabling lifecycle continuity from European development to US commercial supply within one CDMO network. The Phoenix facility supports vials, prefilled syringes ...
COSTA MESA, CA, UNITED STATES, March 19, 2026 /EINPresswire.com/ — Pyramid Pharma Services, a U.S.-based contract development and manufacturing organization (CDMO ...
Eli Lilly is investing $3.5 billion in a new manufacturing facility in Lehigh Valley, Pennsylvania, to produce injectable medicines and devices. The facility will focus on next-generation weight-loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results